Showing results (311-320 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|June 30, 2018
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical TrialVirginia F Borges, Cristiano Ferrario, Nathalie Aucoin, et al.
JAMA Oncology|August 20, 2016
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1Patricia Gaule, James W Smithy, Maria Toki, et al.
JAMA Oncology|August 12, 2018
Optimizing Cancer Treatment Using Game Theory: A ReviewKaterina Stanková, Joel S Brown, William S Dalton, et al.
JAMA Oncology|September 5, 2018
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical TrialCesare Gridelli, Javier de Castro Carpeno, Anne-Marie C Dingemans, et al.
JAMA Oncology|September 2, 2016
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical TrialPeter W Szlosarek, Jeremy P Steele, Luke Nolan, et al.
JAMA Oncology|June 7, 2017
Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical ManagementMonica Morrow, Paul Abrahamse, Timothy P Hofer, et al.
JAMA Oncology|June 7, 2017
The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US PopulationJoseph M Unger, Michael LeBlanc, Charles D Blanke
JAMA Oncology|June 28, 2017
Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation TherapyNariya Cho, Wonshik Han, Boo-Kyung Han, et al.
JAMA Oncology|June 28, 2017
Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus TestingJack Cuzick, Orrin Myers, Ji-Hyun Lee, et al.
JAMA Oncology|April 28, 2017
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 TrialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Pageof 161